Epigenetic age acceleration — measurable via DNA methylation clocks — is detectable not only in colorectal tumors but in histologically normal tissue immediately adjacent to them, a signal that precedes overt malignancy. Across 549 tissue samples (normal mucosa n=96, adjacent mucosa n=245, tumors n=208), six of ten clock models flagged significant age acceleration in adjacent mucosa versus normal tissue, while all ten models flagged tumors. Lifestyle exposures mapped specifically: physical activity attenuated PhenoAge acceleration in adjacent mucosa; smoking history and intensity compressed telomere length (DNAmTL) in tumors; alcohol consumption accelerated Horvath and mitotic clocks in adjacent mucosa.
The finding that epigenetic age acceleration appears in macroscopically normal tissue bordering tumors is the most clinically provocative element here. It suggests the colonic 'field effect' — long theorized in cancer biology as the idea that carcinogenic exposures alter a tissue field before discrete tumors emerge — has a measurable epigenetic fingerprint. This matters for early detection: methylation-based biomarkers in biopsy or stool DNA could theoretically flag at-risk fields before adenomas are visible endoscopically.
Critically, model choice is non-trivial. The Horvath clock best tracked chronological age in normal colon, but mitotic history clocks (EpiTOC, epiTOC2, miAGe) showed the tightest inter-correlation, suggesting distinct biological dimensions. The moderate sample sizes and cross-sectional design limit causal inference — we cannot confirm that lifestyle-driven epigenetic aging drives carcinogenesis rather than co-occurring with it. Still, this is an incremental but genuinely useful advance in mapping where and when epigenetic aging becomes oncologically relevant.
